Deep Track Capital’s Albireo Pharma Inc ALBO Stock Holding History

Deep Track Capital’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,704,000	Closed	-$36.8M	–	76
2022 Q4	$36.8M	Buy	1,704,000 +593,376	+53%	+$12.5M	1.55%	24
2022 Q3	$21.5M	Buy	+1,110,624	New	+$23M	0.98%	38

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Deep Track Capital's ALBO Position: Q1 2023 in Review

Deep Track Capital sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,704,000 shares — an estimated $36.8M sold.

Deep Track Capital first reported a position in ALBO in Q3 2022 and held it in 2 quarters. The position peaked at $36.8M in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Deep Track Capital reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Deep Track Capital sold 1,704,000 Albireo Pharma Inc shares in Q1 2023, an estimated $36.8M.
Deep Track Capital first reported a position in Albireo Pharma Inc in Q3 2022 and held it in 2 quarters.
Deep Track Capital's Albireo Pharma Inc position peaked at $36.8M in Q4 2022.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Deep Track Capital's 13F filing for Q1 2023, filed 15 May 2023.